Fig. 3From: Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastomaMagnetic resonance imaging. Gadolinium-contrast-enhanced T1-weighted 3D magnetic resonance imaging of the brain after radiotherapy (a), before afatinib treatment (b), and after 4Â weeks (c) and 8Â weeks (d) of afatinib treatment. The lesion is indicated by an arrowBack to article page